Edition:
United States

Cardinal Health Inc (CAH)

CAH on New York Consolidated

66.77USD
21 Sep 2017
Change (% chg)

$0.06 (+0.09%)
Prev Close
$66.71
Open
$66.72
Day's High
$67.44
Day's Low
$66.64
Volume
1,452,252
Avg. Vol
2,032,643
52-wk High
$84.88
52-wk Low
$62.70

Chart for

About

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear... (more)

Overall

Beta: 0.87
Market Cap(Mil.): $21,110.62
Shares Outstanding(Mil.): 316.45
Dividend: 0.46
Yield (%): 2.77

Financials

  Industry Sector
P/E (TTM): -- 21.74 16.33
EPS (TTM): -- -- --
ROI: -- 11.98 14.66
ROE: -- 13.67 13.99

BRIEF-Cardinal Health CEO 2017 ‍​total compensation was about $11 mln vs. $13.7 mln in 2016

* CEO George Barrett's 2017 ‍​total compensation was about $11 million versus $13.7 million in 2016 - SEC filing Source text for Eikon: [ID: nEOL4YHpNn] Further company coverage:

9:14am EDT

BRIEF-Cardinal Health increases size of sales facility program to $1 bln

* Cardinal Health - on Aug 30, unit entered into third amendment to the fourth amended and restated receivables purchase agreement - SEC filing‍​

Aug 31 2017

Medtronic misses revenue estimates, shares dip

Medical device maker Medtronic Plc on Tuesday reported quarterly revenue that fell short of Wall Street estimates, hurt by lower sales in its diabetes unit and weak demand for its spine-related products.

Aug 23 2017

UPDATE 3-Medtronic misses revenue estimates, shares dip

* Shares fall as much as 3 pct (Adds details, analysts' comments, updates shares)

Aug 22 2017

RPT-Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals

Aug 3 The largest U.S. retail pharmacies, including Wal-Mart Stores Inc and Walgreens Boots Alliance Inc, are wielding more leverage when buying generic drugs, accelerating a decline in prices likely to affect drug companies for some time, industry experts said on Thursday.

Aug 04 2017

Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals

The largest U.S. retail pharmacies, including Wal-Mart Stores Inc and Walgreens Boots Alliance Inc, are wielding more leverage when buying generic drugs, accelerating a decline in prices likely to affect drug companies for some time, industry experts said on Thursday.

Aug 03 2017

Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals

The largest U.S. retail pharmacies, including Wal-Mart Stores Inc and Walgreens Boots Alliance Inc , are wielding more leverage when buying generic drugs, accelerating a decline in prices likely to affect drug companies for some time, industry experts said on Thursday.

Aug 03 2017

Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals

Aug 3 The largest U.S. retail pharmacies, including Wal-Mart Stores Inc and Walgreens Boots Alliance Inc, are wielding more leverage when buying generic drugs, accelerating a decline in prices likely to affect drug companies for some time, industry experts said on Thursday.

Aug 03 2017

Drug pricing pressure weighs on AmerisourceBergen forecast

Drug distributor AmerisourceBergen Corp cut its fiscal 2017 revenue growth forecast on Thursday and warned investors of the continuing fall in generic drug prices, adding that the pace of branded drug price increases could slow further.

Aug 03 2017

UPDATE 3-Drug pricing pressure weighs on AmerisourceBergen forecast

* Shares fall as much as 11 pct; rivals also slump (Adds conf call details, analysts' comments, updates shares)

Aug 03 2017

Competitors

Earnings vs. Estimates